This inventor holds 1 USPTO granted patent. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Years Active: 2024
Title: Nathan P Martinez: Innovator in Chemical Synthesis
Introduction
Nathan P Martinez is a notable inventor based in Santa Fe, NM (US). He has made significant contributions to the field of chemical synthesis, particularly with his innovative methods for producing complex compounds. His work has implications in various applications, including medical uses.
Latest Patents
Nathan P Martinez holds a patent for the "Synthesis of 6-oxo-1,4,5,6-tetrahydropyridizin-3-carboxylic acid." This patent discloses a method for producing 6-oxo-1,4,5,6-tetrahydropyridazine-3-carboxylic acid. The process involves adding hydrazine sulfate to 2-ketoglutaric acid in a container as a solid, followed by the addition of water to create a heterogeneous mixture. The mixture is then blended for at least one hour, allowing it to convert into the desired compound. The method emphasizes a specific ratio of hydrazine sulfate to 2-ketoglutaric acid, which is greater than 1.1. The compound has various applications, particularly in the medical field, and serves as a product of hydrazine remediation.
Career Highlights
Throughout his career, Nathan P Martinez has focused on advancing chemical synthesis techniques. His innovative approach has led to the development of valuable compounds that have practical applications in medicine and other fields. His work exemplifies the intersection of chemistry and innovation.
Collaborations
Nathan has collaborated with notable colleagues, including Robert Blaskovic and Rudolfo Martinez. These partnerships have contributed to the advancement of his research and the successful development of his patented methods.
Conclusion
Nathan P Martinez is a distinguished inventor whose work in chemical synthesis has led to significant advancements in the production of important compounds. His contributions continue to impact various fields, particularly in medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile